Alysia Roach PHARMD

Recommended Articles

• Croup vs. RSV: How Are They Different?

  Childhood illnesses are very common and can strike at any moment. Croup and RSV are among the most common illnesses that can harm children.CroupCroup is a mild condition, usually nothing to worry about, but it can be scary for parents to witness. This common childhood illness often occurs during the...

• The Impact Parkinson's Disease Has on Driving

  It may start with a tremor followed by muscle stiffness and a decrease range of movement but as Parkinson’s disease progresses so do its side effects. Aside from the well-known and more common symptoms of Parkinson’s disease, a positive diagnosis also means a whole slew of secondary symptoms...

• When Is Sleep Apnea an Issue?

  Sleep apnea is a severe type of sleep disorder that disrupts your breathing while you are asleep. This tends to occur when the brain, as well as the rest of the body, does not get enough oxygen supply. Sleep apnea can affect any individual at any age and it is a potentially life-threatening...

• Managing Anxiety Disorder Using BuSpar

  What is anxiety?Anxiety is a general term that is often used to refer to disorders among individuals that cause nervousness, fear, stress, and worrying. These traits often impact human behavior and can turn into real physical symptoms. Mild anxiety is temporary and vague. However, anxiety that turns...

• What Are the Signs and Symptoms of Type 2 Diabetes?

  Diabetes comes with a lot of signs, so it is important to recognize the signs and symptoms before it is too late. It's important to see your doctor before the symptoms become severe. Type 2 diabetes symptoms often develop slowly and most people don’t even know it. It is really important to get a...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...